Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference

Drug and Alcohol Dependence

Volumn 99, Issue 1-3, 2009, Pages 231-239

  Herrold, Amy A ^a,b   Shen, Fei ^a,b   Graham, Martin P ^b   Harper, Laura K ^a   Specio, Sheila E ^b   Tedford, Clark E ^b,c   Napier, T Celeste ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c OMEROS CORPORATION   (United States)

Author keywords

Associative learning; CREB; ERK; Pharmacotherapy; Psychostimulants; Rat; Serotonin receptors

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; METHAMPHETAMINE; MIRTAZAPINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION; BRAIN TISSUE; CONTROLLED STUDY; DRUG DEPENDENCE; IMMUNOBLOTTING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STATE DEPENDENT LEARNING; VENTRAL TEGMENTUM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; CUES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MEMORY; METHAMPHETAMINE; MIANSERIN; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION; TASTE;

RATTUS;

EID: 57049155395     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.08.005     Document Type: Article

References (55)

1. Ago Y., Nakamura S., Uda M., Kajii Y., Abe M., Baba A., and Matsuda T. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51 (2006) 914-922
2. Arnt J. Inhibitory effects on the discriminative stimulus properties of d-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system. Psychopharmacology (Berl.) 124 (1996) 117-125
3. Arnt J. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur. J. Pharmacol. 283 (1995) 55-62
4. Arolfo M.P., and McMillen B.A. Tiospirone and the reinforcing effects of cocaine in the conditioned place preference paradigm in rats. J. Pharm. Pharmacol. 52 (2000) 977-981
5. Atkins C.M., Selcher J.C., Petraitis J.J., Trzaskos J.M., and Sweatt J.D. The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1 (1998) 602-609
6. Bardo M.T., and Neisewander J.L. Single-trial conditioned place preference using intravenous morphine. Pharmacol. Biochem. Behav. 25 (1986) 1101-1105
7. Bardo M.T., Rowlett J.K., and Harris M.J. Conditioned place preference using opiate and stimulant drugs-a meta-analysis. Neurosci. Biobehav. Rev. 19 (1995) 39-51
8. Bardo M.T., Valone J.M., and Bevins R.A. Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology (Berl.) 143 (1999) 39-46
9. Berendsen H.H., and Broekkamp C.L. Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine. Psychopharmacology (Berl.) 133 (1997) 275-282
10. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Callahan P.M., and Cunningham K.A. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J. Pharmacol. Exp. Ther. 274 (1995) 1414-1424
12. Carlezon Jr. W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends Neurosci. 28 (2005) 436-445
13. Carlezon Jr. W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
14. Chen J.C., Liang K.W., Huang Y.K., Liang C.S., and Chiang Y.C. Significance of glutamate and dopamine neurons in the ventral pallidum in the expression of behavioral sensitization to amphetamine. Life Sci. 68 (2001) 973-983
15. Davidson C., Lazarus C., Xiong X., Lee T.H., and Ellinwood E.H. 5-HT(2) receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur. J. Pharmacol. 453 (2002) 255-263
16. de Boer T.H. The pharmacologic profile of mirtazapine. J. Clin. Psychiatry 57 Suppl. 4 (1996) 19-25
17. de Boer T.H., Maura G., Raiteri M., de Vos C.J., Wieringa J., and Pinder R.M. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers. Neuropharmacology 27 (1988) 399-408
18. Gerdjikov T.V., Ross G.M., and Beninger R.J. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav. Neurosci. 118 (2004) 740-750
19. Gong W., Neill D., and Justice Jr. J.B. 6-Hydroxydopamine lesion of ventral pallidum blocks acquisition of place preference conditioning to cocaine. Brain Res. 754 (1997) 103-112
20. Gonzalez G.A., and Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59 (1989) 675-680
21. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., and Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58 (1992) 1168-1171
22. Halpert A.G., Olmstead M.C., and Beninger R.J. Dimenhydrinate produces a conditioned place preference in rats. Pharmacol. Biochem. Behav. 75 (2003) 173-179
23. Hayase T., Yamamoto Y., and Yamamoto K. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav. Pharmacol. 16 (2005) 395-404
24. King G.R., Xiong Z., Douglass S., and Ellinwood E.H. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur. J. Pharmacol. 394 (2000) 97-101
25. Kongsakon R., Papadopoulos K.I., and Saguansiritham R. Mirtazapine in amphetamine detoxification-a placebo-controlled pilot study. Int. Clin. Psychopharmacol. 20 (2005) 253-256
26. Kuczenski R., Segal D.S., Cho A.K., and Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15 (1995) 1308-1317
27. Leza J.C., Lizasoain I., and Lorenzo P. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen. Pharmacol. 22 (1991) 293-296
28. Lu L., Koya E., Zhai H., Hope B.T., and Shaham Y. Role of ERK in cocaine addiction. Trends Neurosci. 29 (2006) 695-703
29. McDaid J., Graham M.P., and Napier T.C. Methamphetamine-induced sensitization differentially alters pCREB and ΔFosB throughtout the limbic circuit of the mammalian brain. Mol. Pharmacol. 70 (2006) 2064-2074
30. McDaid J., Tedford C.E., Mackie A.R., Dallimore J.E., Mickiewicz A.L., Shen F., Angle J.M., and Napier T.C. Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats. Drug Alcohol Depend. 86 (2007) 55-66 (Ref. type: Abstract)
31. Miller C.A., and Marshall J.F. Altered Fos expression in neural pathways underlying cue-elicited drug seeking in the rat. Eur. J. Neurosci. 21 (2005) 1385-1393
32. Miller C.A., and Marshall J.F. Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47 (2005) 873-884
33. Mizoguchi H., Yamada K., Mizuno M., Mizuno T., Nitta A., Noda Y., and Nabeshima T. Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors 18. Mol. Pharmacol. 65 (2004) 1293-1301
34. Mori T., Narita M., Onodera K., and Suzuki T. Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. Nihon Shinkei Seishin Yakurigaku Zasshi 22 (2002) 73-78
35. Munzar P., Laufert M.D., Kutkat S.W., Novakova J., and Goldberg S.R. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J. Pharmacol. Exp. Ther. 291 (1999) 239-250
36. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl. 1 (2004) 24-32
37. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., and Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22 (1996) 304-312
38. Nomikos G.G., and Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl.) 94 (1988) 119-125
39. Olson V.G., Zabetian C.P., Bolanos C.A., Edwards S., Barrot M., Eisch A.J., Hughes T., Self D.W., Neve R.L., and Nestler E.J. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 25 (2005) 5553-5562
40. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
41. Pereira F.C., Lourenco E.S., Borges F., Morgadinho T., Ribeiro C.F., Macedo T.R., and Ali S.F. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse 60 (2006) 185-193
42. Perugini M., and Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270 (1994) 690-696
43. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon Jr. W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 (2001) 7397-7403
44. Schama K.F., Howell L.L., and Byrd L.D. Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys. Psychopharmacology (Berl.) 132 (1997) 27-34
45. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., and Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18 (1998) 1848-1859
46. Shen F., Meredith G.E., and Napier T.C. Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus. J. Neurosci. 26 (2006) 11041-11051
47. Shepard J.D., Bossert J.M., Liu S.Y., and Shaham Y. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol. Psychiatry 55 (2004) 1082-1089
48. Spyraki C., Fibiger H.C., and Phillips A.G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res. 253 (1982) 185-193
49. Tran-Nguyen L.T., Baker D.A., Grote K.A., Solano J., and Neisewander J.L. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 146 (1999) 60-66
50. Tsuchida K., Akiyama K., Sakai K., Ujike H., Li X., and Kuroda S. Ontogeny of striatal dopamine release in rats after acute administration of methamphetamine. Pharmacol. Biochem. Behav. 53 (1996) 575-580
51. Turgeon S.M., Pollack A.E., and Fink J.S. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. F. Brain Res. 749 (1997) 120-126
52. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm-a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
53. Voigt R.M., Harper L.K., and Napier T.C. The ability of mirtazapine to inhibit the expression of methamphetamine-induced conditined place preference is context independent. Soc. Neurosci. Abstr. (2006) 753 (Ref. type: Abstract)
54. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 36 (2002) 229-240
55. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963